Business Continuity Vital In Japan For Companies Like Daiichi Sankyo On Slow Road To Recovery; Earthquake Impacts Organizational Moves
This article was originally published in PharmAsia News
Executive Summary
TOKYO - An emerging view of the damage to pharmaceutical companies in Japan points to a scenario in which affected companies must find a way to ensure business continuity while simultaneously beginning a slow recovery